Find and Pitch Jounalists, Get Your Story Covered

Tags: Tesla electric vehicles sales IBM qubit

	Profile	Recent Articles on Subject
1	Crystal Phend MedPage Today Contributing editor at MedPage Today. Personal views. HealthcareEditing	SGLT2i Improves Outcomes After TAVI - 17 days ago Wegovy Helps HFpEF Patients With Diabetes Mellitus - about 1 year ago Weight-Loss Drug Benefit Spans HFpEF, HFmrEF - over 1 year ago
2	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	STRIDE: Semaglutide Shows it Has Legs in Peripheral Artery Disease - 17 days ago Tirzepatide's Association With BP Reduction Reinforced With ABPM Data - about 1 year ago And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes - over 1 year ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Lilly, Novo expand DTC reach of obesity meds after compound win - 23 days ago Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments - 2 months ago
4	Kristen Monaco MedPage Today	GLP-1 Agents Not Linked to Post-Op Aspiration Pneumonia, More Data Suggest - about 1 month ago Compounders Sue FDA; Young Women in Perimenopause; More Osteoporosis Biosimilars - about 1 month ago SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease - 2 months ago GLP-1 Agents and Suicide: Making Sense of 2024's Mixed Data - 4 months ago ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up - 4 months ago Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening - 7 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 9 months ago Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers - 9 months ago Farxiga OK'd for Kids; Semaglutide Price Hearing; Maintaining GLP-1 Weight Loss - 10 months ago No Link Between GLP-1 Drugs and Suicide, Says European Regulator - about 1 year ago Wegovy Approved for Heart Disease Prevention - about 1 year ago Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists - over 1 year ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - over 1 year ago Tirzepatide Wins FDA Approval for Weight Loss - over 1 year ago FDA Approves Another SGLT2 Inhibitor for Treating CKD - over 1 year ago FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes - over 1 year ago Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise. - over 1 year ago
5	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial? - 2 months ago Ozempic Linked With Lower Risk of Alzheimer's Diagnosis - 6 months ago Diabetes Drug Shows Benefit in Parkinson's Disease - about 1 year ago Can a GLP-1 Agonist Improve Parkinson's Symptoms? - over 1 year ago
6	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - 4 months ago
7	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - 4 months ago SELECT Trial Data Show Benefit of Semaglutide in Patients With Obesity - over 1 year ago
8	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Pharma giants vie for oral GLP-1R approval - 4 months ago
9	Gillian Booth MedPage Today Singer, social media manager. Philadelphia, Pennsylvania social mediamusic	IG Live December 2: The Weight of Wegovy - 5 months ago
10	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs - 5 months ago SGLT2 Inhibitors Tied to Better NAFLD Outcomes vs Other Antidiabetic Agents - about 1 year ago

Journalists covering peripheral artery disease,Semaglutide ,GLP-1 receptor agonists ,non-diabetic patients with peripheral artery disease